» Articles » PMID: 33678311

Uric Acid and Urate in Urolithiasis: The Innocent Bystander, Instigator, and Perpetrator

Overview
Journal Semin Nephrol
Specialty Nephrology
Date 2021 Mar 8
PMID 33678311
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Uric acid is an end product of purine metabolism in human beings. An unusual and still unexplained phenomenon is that higher primates have relatively high uric acid levels in body fluids owing to a combination of absence of degradation and renal retention. The physiologic purpose of high uric acid levels still is enigmatic, but the pathobiologic burden is a variety of crystallopathies owing to the low aqueous solubility of uric acid such as gouty arthritis and acute uric acid nephropathy. In the urinary space, three distinct conditions result from chronic uric acid and/or urate precipitation. The first and most common variety is uric acid urolithiasis. In this condition, urate is a victim of a systemic metabolic disease in which increased acid load to the kidney is coupled with diminished urinary buffer capacity owing to defective ammonium excretion, resulting in titration of urate to its sparingly soluble protonated counterpart, uric acid, and the formation of stones. Uric acid is the innocent bystander of the crime. The second variety is hyperuricosuric calcium urolithiasis, in which uric acid confers lithogenicity via promotion of calcium oxalate precipitation by multiple mechanisms involving soluble, colloidal, and crystalline urate salts. Uric acid is the instigator of the crime. The third and least common condition involves urate as an integral part of the urolith as an ammonium salt driven by high ammonium and high urate concentrations in urine. Here, uric acid is one of the perpetrators of the crime. Both known and postulated pathogenesis of these three types of urolithiasis are reviewed and summarized.

Citing Articles

Fast Detection of Uric Acid in Urine for Early Diagnosis Using THz Polarized Waves.

Mazaheri Z, Federico G, Koral C, Papari G, Ullatil L, Russo P Sensors (Basel). 2025; 25(4).

PMID: 40006233 PMC: 11859403. DOI: 10.3390/s25041004.


Lychee Peel Extract Ameliorates Hyperuricemia by Regulating Uric Acid Production and Excretion in Mice.

Guo Z, Zhang L, Liu J, Yang Z Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996797 PMC: 11854076. DOI: 10.3390/cimb47020076.


Serum Uric Acid and Bone Health in Middle-Aged and Elderly Hypertensive Patients: A Potential U-Shaped Association and Implications for Future Fracture Risk.

Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H Metabolites. 2025; 15(1).

PMID: 39852358 PMC: 11766991. DOI: 10.3390/metabo15010015.


Causal association of serum vitamin D levels with urolithiasis: a bidirectional two-sample Mendelian randomization study.

Zhang Q, Zhang H, Wang S, Zeng L Eur J Nutr. 2024; 64(1):39.

PMID: 39614876 DOI: 10.1007/s00394-024-03553-1.


Hyperuricemia and its related diseases: mechanisms and advances in therapy.

Du L, Zong Y, Li H, Wang Q, Xie L, Yang B Signal Transduct Target Ther. 2024; 9(1):212.

PMID: 39191722 PMC: 11350024. DOI: 10.1038/s41392-024-01916-y.


References
1.
Coe F, Kavalach A . Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974; 291(25):1344-50. DOI: 10.1056/NEJM197412192912510. View

2.
Sakhaee K . Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol. 2014; 27(3):241-5. PMC: 4696481. DOI: 10.1007/s40620-013-0034-z. View

3.
Klohn M, Bolle J, Reverdin N, Susini A, BAUD C, Graber P . Ammonium urate urinary stones. Urol Res. 1986; 14(6):315-8. DOI: 10.1007/BF00262382. View

4.
Ryall R . Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol. 1997; 15(3):155-64. DOI: 10.1007/BF02201852. View

5.
Patel N, Ward R, Calle J, Remer E, Monga M . Computerized Tomography Based Diagnosis of Visceral Obesity and Hepatic Steatosis is Associated with Low Urine pH. J Urol. 2017; 198(5):1085-1090. DOI: 10.1016/j.juro.2017.05.079. View